The
The results topped
The genetic testing tools company posted revenue of
For the year, the company reported profit of
Illumina expects full-year earnings in the range of
Illumina shares have decreased almost 6% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a
Automated Insights, source